Drug delivery to the inner ear using gene therapy

Area of Science:

• Otolaryngology
• Molecular Biology
• Genetics

Background:

• Gene therapy strategies for inner ear delivery have advanced significantly over the last decade.
• The inner ear is surgically accessible, making it a viable target for therapeutic interventions.
• Gene therapy holds potential as a clinical treatment for various inner ear conditions.

Purpose of the Study:

• To review the development of gene delivery strategies for the inner ear.
• To highlight the potential clinical applications of gene therapy in treating hearing disorders.
• To discuss the safety and efficacy of gene expression in the cochlea.

Main Methods:

• Review of recent scientific literature on inner ear gene therapy.
• Analysis of different vector systems and promoter modifications for targeted gene delivery.
• Examination of animal studies demonstrating successful gene expression in the cochlea.

Main Results:

• Multiple gene delivery strategies have been developed for the inner ear.
• Gene expression in the cochlea has been shown to be safe in animal models, without causing hearing loss.
• Various vectors and promoters allow for tailored gene expression patterns and levels.

Conclusions:

• Gene therapy is a promising approach for inner ear treatment, with potential applications in protection and repair.
• Future directions include single-gene replacement for conditions like connexin mutations and sensory cell regeneration.
• Continued research will enable targeted gene therapies for a range of auditory and vestibular disorders.